{
  "created_at": "Sat Sep 18 8:35:52 +0000 2021",
  "id": 1438968495073595400,
  "id_str": "1438968495073595396",
  "full_text": "Breaking News: In a second vote, an FDA panel recommended authorizing a Pfizer booster for those 65 or older or at high risk of Covid. Earlier, the panel voted against recommending that they be authorized for everyone 16 or older.\nhttps://t.co/9bbreFu2KH",
  "truncated": false,
  "display_text_range": [
    0,
    254
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/9bbreFu2KH",
        "expanded_url": "https://nyti.ms/2VNTRhg",
        "display_url": "nyti.ms/2VNTRhg",
        "indices": [
          231,
          254
        ]
      }
    ]
  },
  "source": "<a href=\"http://www.socialflow.com\" rel=\"nofollow\">SocialFlow</a>",
  "in_reply_to_status_id": null,
  "in_reply_to_status_id_str": null,
  "in_reply_to_user_id": null,
  "in_reply_to_user_id_str": null,
  "in_reply_to_screen_name": null,
  "user": {
    "id": 807095,
    "id_str": "807095",
    "name": "The New York Times",
    "screen_name": "nytimes",
    "location": "New York City",
    "description": "News tips? Share them here: https://t.co/ghL9OoYKMM",
    "url": "http://t.co/ahvuWqicF9",
    "entities": {
      "url": {
        "urls": [
          {
            "url": "http://t.co/ahvuWqicF9",
            "expanded_url": "http://www.nytimes.com/",
            "display_url": "nytimes.com",
            "indices": [
              0,
              22
            ]
          }
        ]
      },
      "description": {
        "urls": [
          {
            "url": "https://t.co/ghL9OoYKMM",
            "expanded_url": "http://nyti.ms/2FVHq9v",
            "display_url": "nyti.ms/2FVHq9v",
            "indices": [
              28,
              51
            ]
          }
        ]
      }
    },
    "protected": false,
    "followers_count": 50512017,
    "friends_count": 850,
    "listed_count": 211023,
    "created_at": "Fri Mar 02 20:41:42 +0000 2007",
    "favourites_count": 18540,
    "utc_offset": null,
    "time_zone": null,
    "geo_enabled": false,
    "verified": true,
    "statuses_count": 447119,
    "lang": null,
    "contributors_enabled": false,
    "is_translator": false,
    "is_translation_enabled": true,
    "profile_background_color": "131516",
    "profile_background_image_url": "http://abs.twimg.com/images/themes/theme14/bg.gif",
    "profile_background_image_url_https": "https://abs.twimg.com/images/themes/theme14/bg.gif",
    "profile_background_tile": true,
    "profile_image_url": "http://pbs.twimg.com/profile_images/1098244578472280064/gjkVMelR_normal.png",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/1098244578472280064/gjkVMelR_normal.png",
    "profile_banner_url": "https://pbs.twimg.com/profile_banners/807095/1584666392",
    "profile_link_color": "607696",
    "profile_sidebar_border_color": "FFFFFF",
    "profile_sidebar_fill_color": "EFEFEF",
    "profile_text_color": "333333",
    "profile_use_background_image": true,
    "has_extended_profile": false,
    "default_profile": false,
    "default_profile_image": false,
    "following": true,
    "follow_request_sent": false,
    "notifications": false,
    "translator_type": "none",
    "withheld_in_countries": []
  },
  "geo": null,
  "coordinates": null,
  "place": null,
  "contributors": null,
  "is_quote_status": false,
  "retweet_count": 256,
  "favorite_count": 490,
  "favorited": false,
  "retweeted": false,
  "possibly_sensitive": false,
  "lang": "en",
  "original_created_at": "Fri Sep 17 20:49:58 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "Breaking Newsです。FDA委員会は2回目の投票で、65歳以上またはコヴィドのリスクが高い人にファイザー社のブースターを認可することを推奨しました。先に、パネルは16歳以上の全員に認可することを推奨することに反対票を投じた。\nhttps://t.co/9bbreFu2KH"
    },
    {
      "locale": "zh",
      "full_text": "爆炸性新闻。在第二次投票中，美国食品和药物管理局的一个小组建议授权为65岁以上或有高风险的科威德人提供辉瑞公司的加强剂。早些时候，该小组投票反对建议为每个16岁或以上的人授权。\nhttps://t.co/9bbreFu2KH"
    },
    {
      "locale": "zh-Hant",
      "full_text": "爆炸性新聞。在第二次投票中，美國食品和藥物管理局的一個小組建議授權爲65歲以上或有高風險的科威德人提供輝瑞公司的加強劑。早些時候，該小組投票反對建議爲每個16歲或以上的人授權。\nhttps://t.co/9bbreFu2KH"
    }
  ]
}